142 related articles for article (PubMed ID: 9426697)
1. Expression of Lamp-1 and Lamp-2 and their interactions with galectin-3 in human tumor cells.
Sarafian V; Jadot M; Foidart JM; Letesson JJ; Van den Brûle F; Castronovo V; Wattiaux R; Coninck SW
Int J Cancer; 1998 Jan; 75(1):105-11. PubMed ID: 9426697
[TBL] [Abstract][Full Text] [Related]
2. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
3. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.
Ohannesian DW; Lotan D; Thomas P; Jessup JM; Fukuda M; Gabius HJ; Lotan R
Cancer Res; 1995 May; 55(10):2191-9. PubMed ID: 7743523
[TBL] [Abstract][Full Text] [Related]
5. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
Bresalier RS; Byrd JC; Wang L; Raz A
Cancer Res; 1996 Oct; 56(19):4354-7. PubMed ID: 8813123
[TBL] [Abstract][Full Text] [Related]
6. LAMP-1 and LAMP-2, but not LAMP-3, are reliable markers for activation-induced secretion of human mast cells.
Grützkau A; Smorodchenko A; Lippert U; Kirchhof L; Artuc M; Henz BM
Cytometry A; 2004 Sep; 61(1):62-8. PubMed ID: 15351990
[TBL] [Abstract][Full Text] [Related]
7. Galaptin-mediated adhesion of human ovarian carcinoma A121 cells and detection of cellular galaptin-binding glycoproteins.
Skrincosky DM; Allen HJ; Bernacki RJ
Cancer Res; 1993 Jun; 53(11):2667-75. PubMed ID: 8347196
[TBL] [Abstract][Full Text] [Related]
8. Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen).
Dong S; Hughes RC
Glycoconj J; 1997 Feb; 14(2):267-74. PubMed ID: 9111144
[TBL] [Abstract][Full Text] [Related]
9. Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma.
Künzli BM; Berberat PO; Zhu ZW; Martignoni M; Kleeff J; Tempia-Caliera AA; Fukuda M; Zimmermann A; Friess H; Büchler MW
Cancer; 2002 Jan; 94(1):228-39. PubMed ID: 11815981
[TBL] [Abstract][Full Text] [Related]
10. Identification of human melanoma cellular and secreted ligands for galectin-3.
Inohara H; Raz A
Biochem Biophys Res Commun; 1994 Jun; 201(3):1366-75. PubMed ID: 8024581
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 stimulates cell proliferation.
Inohara H; Akahani S; Raz A
Exp Cell Res; 1998 Dec; 245(2):294-302. PubMed ID: 9851870
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of lectin-mediated ovarian tumor cell adhesion by sugar analogs.
Woynarowska B; Skrincosky DM; Haag A; Sharma M; Matta K; Bernacki RJ
J Biol Chem; 1994 Sep; 269(36):22797-803. PubMed ID: 8077232
[TBL] [Abstract][Full Text] [Related]
13. The lysosomal membrane glycoproteins Lamp-1 and Lamp-2 are present in mobilizable organelles, but are absent from the azurophil granules of human neutrophils.
Dahlgren C; Carlsson SR; Karlsson A; Lundqvist H; Sjölin C
Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):667-74. PubMed ID: 7487911
[TBL] [Abstract][Full Text] [Related]
14. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor.
Nagy N; Bronckart Y; Camby I; Legendre H; Lahm H; Kaltner H; Hadari Y; Van Ham P; Yeaton P; Pector JC; Zick Y; Salmon I; Danguy A; Kiss R; Gabius HJ
Gut; 2002 Mar; 50(3):392-401. PubMed ID: 11839721
[TBL] [Abstract][Full Text] [Related]
15. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
Plzák J; Smetana K; Hrdlicková E; Kodet R; Holíková Z; Liu FT; Dvoránkova B; Kaltner H; Betka J; Gabius HJ
Int J Oncol; 2001 Jul; 19(1):59-64. PubMed ID: 11408923
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin.
van den Brûle FA; Buicu C; Sobel ME; Liu FT; Castronovo V
Neoplasma; 1995; 42(5):215-9. PubMed ID: 8552198
[TBL] [Abstract][Full Text] [Related]
17. Modulation of lysosomal-associated membrane glycoproteins during retinoic acid-induced embryonal carcinoma cell differentiation.
Amos B; Lotan R
J Biol Chem; 1990 Nov; 265(31):19192-8. PubMed ID: 2172246
[TBL] [Abstract][Full Text] [Related]
18. Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils.
Feuk-Lagerstedt E; Jordan ET; Leffler H; Dahlgren C; Karlsson A
J Immunol; 1999 Nov; 163(10):5592-8. PubMed ID: 10553088
[TBL] [Abstract][Full Text] [Related]
19. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3.
Bresalier RS; Mazurek N; Sternberg LR; Byrd JC; Yunker CK; Nangia-Makker P; Raz A
Gastroenterology; 1998 Aug; 115(2):287-96. PubMed ID: 9679034
[TBL] [Abstract][Full Text] [Related]
20. Cell surface expression of lysosome-associated membrane proteins (LAMPs) in scleroderma: relationship of lamp2 to disease duration, anti-Sc170 antibodies, serum interleukin-8, and soluble interleukin-2 receptor levels.
Holcombe RF; Baethge BA; Stewart RM; Betzing K; Hall VC; Fukuda M; Wolf RE
Clin Immunol Immunopathol; 1993 Apr; 67(1):31-9. PubMed ID: 8443983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
